“Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022060, Jun. 2022, doi: 10.4084/MJHID.2022.060.